The systems and methods can provide continuous, efficient, accurate, non-contact, monitoring of one or more cardiorespiratory and/or behavior parameters associated with a subject in a defined environment using at least non-contact sensor data and provide feedback based on the determined parameters. The system can include one or more sensor modules disposed within defined environment(s). The system may further include one or more sensors disposed at a specific spatial location in the defined environment. The sensor(s) may include non-contact electric field sensor(s) configured to record non-contact sensor data related to one or more periods of stillness and/or movement of the subject. The system may further include one or more processors configured to determine cardiorespiratory respiratory parameters and/or behavior parameters using the non-contact sensor data. Because the systems and methods also allow for continuous collection of measurable variables, they can provide a high-throughput quantifiable record of the subject's physio-behavioral self.

Central nervous (“CNS”) health in subjects who have human immunodeficiency virus (“HIV”) or non-human-species analogs thereof is 102 evaluated or otherwise monitored by analyzing frequency following response (“FFR”). In general, one or more components of an FFR are analyzed, The FFR is measured in response to the administration of an acoustic stimulus to the subject. The acoustic stimulus includes a complex sound, which may include a consonant and a consonant-to-vowel transition. An indication of CNS health can be generated by measuring changes in the FFR components (e.g., over time or relative to normative data).

The present invention is directed to a method for determining a paroxysmal slow waves event (PSWE) so as to determine blood-brain barrier dysfunction (BBBD) or increased risk of developing a neurological disease or disorder in a subject.

A training pad system for house training of a pet or toilet training of a juvenile human, includes a training pad with one or more diagnostic zones, each comprising one or more diagnostic test areas, optionally a pad cutout that matches a shape of a lower portion of a toilet, a urine indicator composition for visually indicating exposure to urine with a signal color, a liquid absorbing material, an antimicrobial agent, and adhesive surfaces; and a diagnostic decoding chart to interpret diagnostic results by lookup of corresponding test decoding areas.

A method for detecting estrus in sows where insemination is carried out when a determination has been made. In a first method images of a rear profile of each sow are analyzed to make a determination from features relating to a shape, size, and/or color of the vulva whether the sow is in estrus. The analysis can use a program where a large number of images showing the vulva area of a plurality of sows known to be in estrus and known not to be in estrus have been previously analyzed to generate data on the previous images to create a program which generates a signal using the data to make the determination. In a second method a boar is confined and brought into close contact with the sows where images and/or sounds of each sow are analyzed to make a determination whether the sow is in estrus.

Genetically encoded calcium indicator (GECI) polypeptides and the nucleic acid molecules encoding such polypeptides are provided.

A wearable device for monitoring medical properties of a patient, the device having a rigid frame, multiple members coupled to the rigid frame, and a housing having an electrical circuit, where the housing is secured to the rigid frame, where the rigid frame surrounds a void, and where the void is configured to accommodate a bottom surface of the housing.

The present disclosure relates to an oral cavity based device, system and toolkit which identifies the human or animal through the unique demarcations oral cavity. These unique demarcations are described as “oralsprint” identifiers (IDs) used to both identify and measure saliva-based biologics and other biometrics through one or more electronic sensors and related technologies for humans and animals to herein as ORAL AND SALIVA BASED EQUINE ID DRUG MONITORING.

The disclosure provides a cranial rotation system, including a subject stage configured to support a subject; a cranial support configured to support a cranium of the subject and rotate relative to the subject stage; subject stage a motor configured to rotate the cranial support about a rotational axis; and a controller configured to operate the motor.

A software application platform which provides a user with the ability to receive customized information relating to an animal's health and/or optimal growth as displayed on a graphical user interface. Specifically, a user may input data (and the system may receive said input data), for example, an animal specific biomarker, and subsequently receive identification relating to a specific subgroup of individual animal(s) who are at risk for growth abnormalities, and further receive information, data, and customized recommendations and/or intervention steps for the specific at risk animal relating to the animal's health, growth abnormality, or similar feature based on an analysis and determination of the biomarker as compared to a reference database.